Tech Moves: Allen Institute names new VP; Nordstrom board member steps down; and more Julie Harris has been appointed vice president of The Paul G. Allen Frontiers Group at the Seattle-based Allen Institute. Harris… Read More
How Pfizer’s $43 billion acquisition of Seagen could impact the biotech industry in Seattle Biopharma acquisitions often come with layoffs and lab shutdowns as smaller companies get absorbed. Whether that happens to Seagen is… Read More
The first 10 calls every life science entrepreneur should make William Canestaro has nurtured a lot of startups. As managing director of Washington Research Foundation and WRF Capital, the foundation’s… Read More
Biotech industry leaders share cautious optimism for 2023 amid downturn and layoffs Sujal Patel has been here before. He weathered the 2009 recession as CEO of Isilon Systems, coming out the other… Read More
Tech Moves: Glassdoor hires former Convoy chief economist; Kineta adds exec; and more — Maggie Brady, previously a human resources group leader at fintech company Fiserv, is now head of people at trucking… Read More
Merck reportedly eyeing acquisition of Seattle biotech giant Seagen Biopharma giant Merck is considering an acquisition of Seagen, the Seattle area’s biggest biotech company, according to a report in… Read More
Juno’s lasting legacy: How the cell therapy juggernaut influenced biotech in Seattle and beyond When Juno Therapeutics launched in 2013, cell therapy was a nascent field. Early clinical studies were showing dramatic rates of… Read More
Geek of the Week: Science, tech and startups fuel William Canestaro at Wash. Research Foundation William Canestaro is keenly aware of the risk startup founders take when they go all in to start a company.… Read More
